Urgent

Neuropsychiatric systemic lupus erythematosus

CNS lupus / lupus cerebritis · Rheumatology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Diverse central and peripheral nervous system involvement in SLE ranging from seizures, psychosis and acute confusional state to stroke, myelitis and aseptic meningitis. The challenge is distinguishing active inflammatory/thrombotic lupus from infection, metabolic causes and drug effects.

Red flags

  • Reduced GCS or status epilepticus
  • Acute focal neurological deficit (stroke)
  • Signs of raised intracranial pressure
  • Fever and meningism (infection must be excluded)
  • Transverse myelitis with sphincter involvement

Assessment

Differential diagnosis

  • CNS infection (meningitis/encephalitis)
  • Antiphospholipid-related thrombotic stroke
  • Metabolic encephalopathy (uraemia, hyponatraemia)
  • Steroid-induced psychosis
  • Posterior reversible encephalopathy syndrome (PRES)
  • Primary psychiatric illness

Investigations

  • MRI brain (and cord if myelitis) with contrast
  • Lumbar puncture (cell count, protein, cultures, oligoclonal bands, exclude infection)
  • Anti-dsDNA, complement C3/C4, ANA, antiphospholipid antibodies
  • EEG if seizures/encephalopathy
  • FBC, U&E, glucose, calcium, blood cultures
  • CT if acute focal deficit to exclude haemorrhage/infarct

Management

  • Stabilise (ABC), protect airway if reduced consciousness, treat seizures
  • Exclude infection and metabolic causes before attributing to lupus - do LP and cultures
  • Distinguish inflammatory (cerebritis, myelitis) from thrombotic (antiphospholipid) mechanisms
  • For inflammatory NPSLE, start high-dose corticosteroid and plan induction immunosuppression
  • Add cyclophosphamide or rituximab for severe/organ-threatening inflammatory disease
  • For thrombotic/antiphospholipid-mediated events, anticoagulate rather than immunosuppress
  • Treat seizures and psychiatric symptoms symptomatically alongside immunosuppression
  • Monitor response clinically and with serology; involve neurology and psychiatry

Drugs & doses

Methylprednisolone — 500 mg-1 g IV OD x3 for severe inflammatory NPSLE
Prednisolone — 1 mg/kg/day PO following pulses
Cyclophosphamide — 500-1000 mg/m2 IV monthly (NIH/Euro-Lupus regimens)
Rituximab — 1 g IV days 1 and 15 for refractory disease
Levetiracetam — 500 mg-1 g IV/PO BD for seizures
Warfarin / LMWH — therapeutic anticoagulation if thrombotic antiphospholipid mechanism

Disposition

Admit (HDU/ICU if reduced consciousness or seizures) under combined rheumatology-neurology care after excluding infection.

Complications & pitfalls

  • Permanent neurological deficit
  • Status epilepticus
  • Stroke / recurrent thrombosis
  • Secondary infection from immunosuppression
  • Cognitive impairment

Exam pearls

  • Low complement and high anti-dsDNA support active inflammatory lupus; antiphospholipid antibodies point to a thrombotic mechanism needing anticoagulation
  • Always exclude infection before escalating immunosuppression
  • Steroid psychosis can mimic NPSLE - timing and dose help differentiate
  • Transverse myelitis is a neurological emergency - treat within hours

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.